109 related articles for article (PubMed ID: 21233105)
1. Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomy.
Hashine K; Yuasa A; Shinomori K; Shirato A; Ninomiya I; Teramoto N
Jpn J Clin Oncol; 2011 Apr; 41(4):571-6. PubMed ID: 21233105
[TBL] [Abstract][Full Text] [Related]
2. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA
Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
[TBL] [Abstract][Full Text] [Related]
3. Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up.
Menon M; Bhandari M; Gupta N; Lane Z; Peabody JO; Rogers CG; Sammon J; Siddiqui SA; Diaz M
Eur Urol; 2010 Dec; 58(6):838-46. PubMed ID: 20869162
[TBL] [Abstract][Full Text] [Related]
4. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
Carini M; Masieri L; Minervini A; Lapini A; Serni S
Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
[TBL] [Abstract][Full Text] [Related]
5. Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
Lughezzani G; Budäus L; Isbarn H; Sun M; Perrotte P; Haese A; Chun FK; Schlomm T; Steuber T; Heinzer H; Huland H; Montorsi F; Graefen M; Karakiewicz PI
Eur Urol; 2010 Apr; 57(4):562-8. PubMed ID: 20018437
[TBL] [Abstract][Full Text] [Related]
6. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S
J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
[TBL] [Abstract][Full Text] [Related]
7. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
[TBL] [Abstract][Full Text] [Related]
8. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
9. Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens.
Whittemore DE; Hick EJ; Carter MR; Moul JW; Miranda-Sousa AJ; Sexton WJ
J Urol; 2008 Feb; 179(2):516-22; discussion 522. PubMed ID: 18076949
[TBL] [Abstract][Full Text] [Related]
10. Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.
Sim HG; Telesca D; Culp SH; Ellis WJ; Lange PH; True LD; Lin DW
J Urol; 2008 May; 179(5):1775-9. PubMed ID: 18343432
[TBL] [Abstract][Full Text] [Related]
11. Pathologic T2 stage subgroups and recurrence-free survival after radical prostatectomy.
DeCastro GJ; McCann T; Benson MC; McKiernan JM
Urology; 2008 Dec; 72(6):1214-8. PubMed ID: 18597825
[TBL] [Abstract][Full Text] [Related]
12. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.
Boorjian SA; Thompson RH; Tollefson MK; Rangel LJ; Bergstralh EJ; Blute ML; Karnes RJ
Eur Urol; 2011 Jun; 59(6):893-9. PubMed ID: 21388736
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
Gupta A; Lotan Y; Ashfaq R; Roehrborn CG; Raj GV; Aragaki CC; Montorsi F; Shariat SF
Eur Urol; 2009 May; 55(5):1124-33. PubMed ID: 18585843
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy and prognostic factors.
du Fossé W; Billiet I; Mattelaer J
Acta Urol Belg; 1997 Oct; 65(3):53-62. PubMed ID: 9421937
[TBL] [Abstract][Full Text] [Related]
15. [Value of positive resection margins in patients with pT2 prostate cancer. Implications for adjuvant treatment].
Rosas-Nava JE; Herranz-Amo F; Paños-Fagundo EV; Lledó-García E; Verdú-Tartajo F; Hernández-Fernández C
Actas Urol Esp; 2011 May; 35(5):272-6. PubMed ID: 21397985
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
[TBL] [Abstract][Full Text] [Related]
17. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
18. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
[TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
Yossepowitch O; Eggener SE; Bianco FJ; Carver BS; Serio A; Scardino PT; Eastham JA
J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
[TBL] [Abstract][Full Text] [Related]
20. Early oncological outcomes of robot-assisted radical prostatectomy for high-grade prostate cancer.
Wambi CO; Siddiqui SA; Krane LS; Agarwal PK; Stricker HJ; Peabody JO
BJU Int; 2010 Dec; 106(11):1739-45. PubMed ID: 20575980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]